ReachMD

Episodes 1-3 of 3

• • 

    

    Karen L. Reckamp, MS, MD

    Peer

  • 

    

    Mark A. Socinski, MD

    Peer

  • 

    

    Helena Yu, MD

    Peer

  4

  

  RestartResume

  Advanced/Metastatic NSCLC Treatment: Advancements for Patients Without Target...

• • 

    

    Mark A. Socinski, MD

    Peer

  3

  

  RestartResume

  Optimizing Immunotherapy in NSCLC: Updates from Trials on Agents Targeting PD-L1

• • 

    

    Robert Mocharnuk, MD

    Peer

  • 

    

    Ingrid A. Mayer, MD

    Peer

  2

  

  RestartResume

  HR+/HER2-Negative Breast Cancer: Revolutions in Precision Medicine with PI3K ...